NL-OMON53821撤回3 期
Implementation of prehospital high Sensitive troponin and risk Stratification- validation phase - IMPRESS-validation
Ambulancezorg Rotterdam-Rijnmond ARR0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria: >= 18 age with acute chest pain suggestive of cardiac
- •chest pain or acute coronary syndrome.
排除标准
- •A potential subject who meets any of the following criteria will be excluded
- •from participation in this study: ST-elevation on ECG, new left bundle branch
- •block, systolic blood pressure below 90 mmHg, tachycardia above 140 beats per
- •minute, clinical instability, signs of acute heart failure, terminal kidney
- •failure, pregnancy, life expectancy of less than 3 months, obvious non cardiac
- •cause of acute chest pain, inability to provide a written informed consent or
- •inappropriate knowledge of English or Dutch language.
研究者
相似试验
招募中
不适用
Developement of prehospital diagnostic scale for stroke and acute coronary syndromeJPRN-UMIN000031197Chiba University Graduate School of Medicine, Department of Emergency and Critical Care Medicine3,000
尚未招募
不适用
Prehospital study to the use of HEART-score in chest pain patientspijn op de borst klachtenACSChest painACSNL-OMON26498.W.P.L. van der Waarden, Student Nurse practitionerAmbulancezorg Rotterdam-Rijnmond AZRRBreslau 22993 LT BarendrechtE-mail: nvanderwaarden@azrr.nl600
已完成
不适用
Prehospital Evaluation and Detection of Induced Coagulopathy in TraumaTRAUMAINDIZIERTEKOAGULOPATHIED65Disseminated intravascular coagulation [defibrination syndrome]DRKS00009559Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin148
招募中
不适用
Clinical Trial for Preoperative High Intensity Interval Training (HIT) Prior to Oncological EsophagectomyC15.1Thoracic part of oesophagusDRKS00024938niversitätsklinikum Mannheim20
招募中
4 期
sing Tocilizumab in critically ill patients with COVID-19.Coronaviruses infectionsC01.925.782.600.550.200RBR-3zdynpVictor Côrtes Pourchet de Carvalho